Literature DB >> 1375569

Connections: heart disease, cellular electrophysiology, and ion channels.

R E ten Eick1, D W Whalley, H H Rasmussen.   

Abstract

Our purpose in this article is to examine the hypothesis that both myocardial disease and ischemia can alter the electrophysiologic function of the ion channels responsible for the cellular electrical activity of the heart. Changes in the intracellular and extracellular milieus occur during ischemia and can alter the electrophysiology of several species of ionic channels and the cellular electrophysiologic activity of cardiac myocytes. Included are 1) changes in extracellular [K+] and pH and in intracellular [Na+], [Ca2+], and pH; 2) accumulation of noxious metabolic products such as lysophosphatidylcholine; and 3) depletion of intracellular ATP. Finally, ischemia or disease (e.g., hypertrophy) can alter the electrophysiology of at least two types of K+ channels, the A-like channels underlying the transient outward current and the inward rectifier, by mechanisms that apparently do not involve alteration of either the intra- or extracellular milieus. Findings suggest that the expression of cardiac A-like channel function can be altered by hypertrophy and that at least one intrinsic conductance property of the inward rectifier can be altered by ischemia. We speculate that the control of expression, function, and regulation of cardiac ion channels can be affected at the molecular level by heart disease and myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375569     DOI: 10.1096/fasebj.6.8.1375569

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.

Authors:  Elsayed Z Soliman; Amit J Shah; Andrew Boerkircher; Yabing Li; Pentti M Rautaharju
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-04-24

2.  Prediction of the onset of atrial fibrillation after cardiac surgery using the monophasic action potential.

Authors:  A M Pichlmaier; V Lang; W Harringer; B Heublein; M Schaldach; A Haverich
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

3.  A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study.

Authors:  S Dhein; N Manicone; A Müller; R Gerwin; U Ziskoven; A Irankhahi; C Minke; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

4.  Enhanced functional expression of transient outward current in hypertrophied feline myocytes.

Authors:  R E Ten Eick; K Zhang; R D Harvey; A L Bassett
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

5.  Activation of potassium channels contributes to hypoxic injury in proximal tubules.

Authors:  W B Reeves; S V Shah
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 6.  The cardiac renin-angiotensin system: physiological relevance and pharmacological modulation.

Authors:  J Holtz
Journal:  Clin Investig       Date:  1993

7.  A novel enhancing effect of clofilium on transient outward-type cloned cardiac K+ channel currents.

Authors:  T Kobayashi; G Mikala; A Yatani
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Basal late sodium current is a significant contributor to the duration of action potential of guinea pig ventricular myocytes.

Authors:  Yejia Song; Luiz Belardinelli
Journal:  Physiol Rep       Date:  2017-05

9.  Reduction in dynamin-2 is implicated in ischaemic cardiac arrhythmias.

Authors:  Dan Shi; Duanyang Xie; Hong Zhang; Hong Zhao; Jian Huang; Changming Li; Yi Liu; Fei Lv; Erlinda The; Yuan Liu; Tianyou Yuan; Shiyi Wang; Jinjin Chen; Lei Pan; Zuoren Yu; Dandan Liang; Weidong Zhu; Yuzhen Zhang; Li Li; Luying Peng; Jun Li; Yi-Han Chen
Journal:  J Cell Mol Med       Date:  2014-08-05       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.